

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.72411278 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72411278 |
| 3 | positive thymic T cell selection (GO:0045059) | 4.79606925 |
| 4 | negative thymic T cell selection (GO:0045060) | 4.72757686 |
| 5 | negative T cell selection (GO:0043383) | 4.71771505 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.71416235 |
| 7 | sodium ion export (GO:0071436) | 4.68138293 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.67586387 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.58136765 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.57644440 |
| 11 | thymic T cell selection (GO:0045061) | 4.38596923 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34111546 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34111546 |
| 14 | regulation of ARF protein signal transduction (GO:0032012) | 4.22049746 |
| 15 | positive T cell selection (GO:0043368) | 4.11286332 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00174517 |
| 17 | T cell selection (GO:0045058) | 3.97946839 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.94075781 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85679230 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75578447 |
| 21 | response to peptidoglycan (GO:0032494) | 3.74724638 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.71822930 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.70410968 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.64128240 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.61315799 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.58095176 |
| 27 | response to interleukin-15 (GO:0070672) | 3.55888220 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 3.55470385 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.51566997 |
| 30 | detection of bacterium (GO:0016045) | 3.47998539 |
| 31 | positive regulation of histone deacetylation (GO:0031065) | 3.45727305 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43617621 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.42731889 |
| 34 | detection of other organism (GO:0098543) | 3.42223050 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.40077378 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38801719 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38801719 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.38801719 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38801719 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.38801719 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38801719 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.31175076 |
| 43 | leukocyte aggregation (GO:0070486) | 3.26863578 |
| 44 | response to muramyl dipeptide (GO:0032495) | 3.23835870 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.23321658 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.21364593 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.21019336 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.21019336 |
| 49 | response to type I interferon (GO:0034340) | 3.19832704 |
| 50 | potassium ion import (GO:0010107) | 3.17539926 |
| 51 | regulation of ARF GTPase activity (GO:0032312) | 3.17198710 |
| 52 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.16473199 |
| 53 | peptidyl-lysine dimethylation (GO:0018027) | 3.15575102 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.15268565 |
| 55 | positive regulation of Rap GTPase activity (GO:0032854) | 3.12822704 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11933579 |
| 57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.09756289 |
| 58 | establishment of nucleus localization (GO:0040023) | 3.05895468 |
| 59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03792269 |
| 60 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00012625 |
| 61 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.98542360 |
| 62 | signal complex assembly (GO:0007172) | 2.96591278 |
| 63 | negative regulation of type 2 immune response (GO:0002829) | 2.96571118 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95807917 |
| 65 | alanine transport (GO:0032328) | 2.95145496 |
| 66 | negative regulation of innate immune response (GO:0045824) | 2.92360466 |
| 67 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.92122198 |
| 68 | cellular response to interleukin-15 (GO:0071350) | 2.91644306 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90840595 |
| 70 | negative regulation of cell size (GO:0045792) | 2.90436617 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90420813 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89375260 |
| 73 | stress granule assembly (GO:0034063) | 2.88734077 |
| 74 | regulation of defense response to virus by virus (GO:0050690) | 2.88418124 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87236619 |
| 76 | germinal center formation (GO:0002467) | 2.86058795 |
| 77 | detection of external biotic stimulus (GO:0098581) | 2.85431278 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84255989 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 2.82635087 |
| 80 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81380052 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.77930626 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.77930626 |
| 83 | positive regulation of synapse maturation (GO:0090129) | 2.77393174 |
| 84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77222416 |
| 85 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.76857841 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76284123 |
| 87 | regulation of superoxide anion generation (GO:0032928) | 2.76202517 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 2.75635639 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75384568 |
| 90 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.74057750 |
| 91 | exploration behavior (GO:0035640) | 2.73970191 |
| 92 | positive regulation of isotype switching (GO:0045830) | 2.73818775 |
| 93 | lymphocyte migration (GO:0072676) | 2.73645069 |
| 94 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.73604055 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72914737 |
| 96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.71155137 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 2.70797173 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70202560 |
| 99 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70034082 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.69970732 |
| 101 | regulation of T cell tolerance induction (GO:0002664) | 2.69582346 |
| 102 | neurotransmitter secretion (GO:0007269) | 2.68704438 |
| 103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.67847328 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67514646 |
| 105 | response to protozoan (GO:0001562) | 2.67160793 |
| 106 | natural killer cell differentiation (GO:0001779) | 2.67077900 |
| 107 | pre-miRNA processing (GO:0031054) | 2.66619932 |
| 108 | regulation of Rap GTPase activity (GO:0032317) | 2.66213003 |
| 109 | defense response to protozoan (GO:0042832) | 2.65973475 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65563055 |
| 111 | cellular sodium ion homeostasis (GO:0006883) | 2.64982736 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.64473822 |
| 113 | B cell mediated immunity (GO:0019724) | 2.63273648 |
| 114 | granulocyte activation (GO:0036230) | 2.62795013 |
| 115 | regulation of necroptotic process (GO:0060544) | 2.62623658 |
| 116 | myeloid dendritic cell activation (GO:0001773) | 2.62608744 |
| 117 | response to pheromone (GO:0019236) | 2.62397232 |
| 118 | neuromuscular process controlling balance (GO:0050885) | 2.60104132 |
| 119 | regulation of antigen processing and presentation (GO:0002577) | 2.59857527 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.57613305 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57139117 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.57135245 |
| 123 | activation of JUN kinase activity (GO:0007257) | 2.54717619 |
| 124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54501755 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.54376142 |
| 126 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54308857 |
| 127 | T cell costimulation (GO:0031295) | 2.54187769 |
| 128 | cerebellar Purkinje cell layer development (GO:0021680) | 2.52677381 |
| 129 | neutrophil activation (GO:0042119) | 2.52472688 |
| 130 | pinocytosis (GO:0006907) | 2.52396295 |
| 131 | regulation of mast cell degranulation (GO:0043304) | 2.51724455 |
| 132 | gamma-aminobutyric acid transport (GO:0015812) | 2.51664452 |
| 133 | B cell receptor signaling pathway (GO:0050853) | 2.51614992 |
| 134 | prepulse inhibition (GO:0060134) | 2.51458909 |
| 135 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.51283716 |
| 136 | T cell migration (GO:0072678) | 2.49409329 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.49156382 |
| 138 | regulation of necrotic cell death (GO:0010939) | 2.48752972 |
| 139 | lymphocyte costimulation (GO:0031294) | 2.48441867 |
| 140 | positive regulation of RNA splicing (GO:0033120) | 2.47658714 |
| 141 | synaptic vesicle exocytosis (GO:0016079) | 2.47162375 |
| 142 | regulation of cholesterol homeostasis (GO:2000188) | 2.46806547 |
| 143 | respiratory burst (GO:0045730) | 2.46621413 |
| 144 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46185624 |
| 145 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45906784 |
| 146 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.45831310 |
| 147 | vocalization behavior (GO:0071625) | 2.44510734 |
| 148 | cellular extravasation (GO:0045123) | 2.44227230 |
| 149 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.43626773 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.43626773 |
| 151 | interferon-gamma production (GO:0032609) | 2.41951519 |
| 152 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41933162 |
| 153 | lymphocyte chemotaxis (GO:0048247) | 2.40454325 |
| 154 | dendrite morphogenesis (GO:0048813) | 2.39902991 |
| 155 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.39159627 |
| 156 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.38598703 |
| 157 | positive regulation of B cell mediated immunity (GO:0002714) | 2.38598703 |
| 158 | glutamate secretion (GO:0014047) | 2.38431991 |
| 159 | negative regulation of protein oligomerization (GO:0032460) | 2.38378002 |
| 160 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.38202515 |
| 161 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.37404988 |
| 162 | response to host immune response (GO:0052572) | 2.37404988 |
| 163 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.36665943 |
| 164 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.36665943 |
| 165 | dendritic cell chemotaxis (GO:0002407) | 2.36601783 |
| 166 | receptor catabolic process (GO:0032801) | 2.36572664 |
| 167 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.36044935 |
| 168 | negative regulation of fibrinolysis (GO:0051918) | 2.35970545 |
| 169 | histone H4-K16 acetylation (GO:0043984) | 2.34570427 |
| 170 | glial cell proliferation (GO:0014009) | 2.33678462 |
| 171 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.30422115 |
| 172 | Golgi transport vesicle coating (GO:0048200) | 2.27748115 |
| 173 | COPI coating of Golgi vesicle (GO:0048205) | 2.27748115 |
| 174 | mannose metabolic process (GO:0006013) | 2.27264283 |
| 175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26513040 |
| 176 | long-term memory (GO:0007616) | 2.25611705 |
| 177 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.25181855 |
| 178 | positive regulation of protein deacetylation (GO:0090312) | 2.24716244 |
| 179 | adaptation of signaling pathway (GO:0023058) | 2.23987863 |
| 180 | clathrin coat assembly (GO:0048268) | 2.22882863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 4.08111400 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.61537293 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.02900556 |
| 4 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.99758448 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97361639 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.88938403 |
| 7 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.81259862 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.73026511 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69406995 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.61591499 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.45845480 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42775959 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.37860792 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29220630 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.27161469 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.26705748 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.20353570 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19347814 |
| 19 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.14937691 |
| 20 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.06765519 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02089942 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99489658 |
| 23 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.99319814 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.98992245 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98123884 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98070973 |
| 27 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.95739553 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95574496 |
| 29 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.94391141 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.92849276 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90677971 |
| 32 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89852577 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88824710 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87217097 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86541039 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84666835 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82368685 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.81488399 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80279203 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79193326 |
| 41 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.78686339 |
| 42 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.70703536 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69258551 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67211252 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65090847 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58111311 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.57275820 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.56359290 |
| 49 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.55866385 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.55391662 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55277564 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54814997 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.53811602 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53371594 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53031991 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.51825294 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51807629 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50535515 |
| 59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50135134 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49936104 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49252542 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48133893 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47640838 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.47357372 |
| 65 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46873801 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46870567 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46645377 |
| 68 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.45747459 |
| 69 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.45135676 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44843966 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44393109 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41368225 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41272224 |
| 74 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.39848491 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39030793 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38047758 |
| 77 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37377771 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34921096 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33162504 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33034296 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32245729 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31614363 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28547948 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28470243 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28321259 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27322127 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27102242 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27027315 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25428909 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24304474 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22903483 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21706630 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21065427 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20742482 |
| 95 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20635365 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20405621 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19795675 |
| 98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18909642 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18305574 |
| 100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16461380 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16170802 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15118450 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15012387 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14329229 |
| 105 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13770538 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13020194 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12938932 |
| 108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12661498 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11970715 |
| 110 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11848470 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11590458 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11464717 |
| 113 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11427913 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11271823 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11210331 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10823411 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10013122 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08324660 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08190290 |
| 120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08123016 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07923237 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07731951 |
| 123 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06471021 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06415887 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06257867 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04762139 |
| 127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04376703 |
| 128 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03703314 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01772222 |
| 130 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00964742 |
| 131 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00669221 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00334662 |
| 133 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99075621 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98673009 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97018538 |
| 136 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96607498 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93985114 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93005479 |
| 139 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92497597 |
| 140 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91395859 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90325447 |
| 142 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90099020 |
| 143 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90030430 |
| 144 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88960669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.03724578 |
| 2 | MP0003436_decreased_susceptibility_to | 3.78464353 |
| 3 | MP0008961_abnormal_basal_metabolism | 3.50180009 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.32145991 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.21081937 |
| 6 | MP0006082_CNS_inflammation | 2.84684146 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.70649651 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.68772656 |
| 9 | MP0005451_abnormal_body_composition | 2.65453640 |
| 10 | MP0009785_altered_susceptibility_to | 2.58101446 |
| 11 | MP0003724_increased_susceptibility_to | 2.56445979 |
| 12 | MP0005025_abnormal_response_to | 2.51927490 |
| 13 | MP0002419_abnormal_innate_immunity | 2.50699362 |
| 14 | MP0002822_catalepsy | 2.50442724 |
| 15 | MP0000685_abnormal_immune_system | 2.48161977 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.45012553 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.38338054 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.34129877 |
| 19 | MP0003303_peritoneal_inflammation | 2.26735243 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.21900487 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.10956465 |
| 22 | MP0008260_abnormal_autophagy | 2.09344556 |
| 23 | MP0008569_lethality_at_weaning | 2.05094349 |
| 24 | MP0003329_amyloid_beta_deposits | 2.00689330 |
| 25 | MP0000858_altered_metastatic_potential | 1.97655534 |
| 26 | MP0002132_abnormal_respiratory_system | 1.94428183 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.91697226 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.85102374 |
| 29 | MP0002405_respiratory_system_inflammati | 1.83572827 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.83231521 |
| 31 | MP0005671_abnormal_response_to | 1.80451869 |
| 32 | MP0004130_abnormal_muscle_cell | 1.80425057 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.79965660 |
| 34 | MP0003866_abnormal_defecation | 1.78974386 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.75185811 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.74209635 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.70845830 |
| 38 | MP0001873_stomach_inflammation | 1.70132756 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.64353028 |
| 40 | MP0004510_myositis | 1.64346803 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.63257850 |
| 42 | MP0002398_abnormal_bone_marrow | 1.63046075 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.61452133 |
| 44 | MP0008469_abnormal_protein_level | 1.57902675 |
| 45 | MP0009745_abnormal_behavioral_response | 1.55504189 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.55247594 |
| 47 | MP0001800_abnormal_humoral_immune | 1.54726988 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.48196487 |
| 49 | MP0009764_decreased_sensitivity_to | 1.48150728 |
| 50 | MP0000604_amyloidosis | 1.46940260 |
| 51 | MP0002064_seizures | 1.45893937 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.45160341 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.43610560 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.40580757 |
| 55 | MP0001790_abnormal_immune_system | 1.36754313 |
| 56 | MP0005387_immune_system_phenotype | 1.36754313 |
| 57 | MP0001853_heart_inflammation | 1.34286407 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.28323913 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.26872261 |
| 60 | MP0002722_abnormal_immune_system | 1.24848656 |
| 61 | MP0001819_abnormal_immune_cell | 1.23110805 |
| 62 | MP0009278_abnormal_bone_marrow | 1.22793299 |
| 63 | MP0000716_abnormal_immune_system | 1.22662950 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.22024297 |
| 65 | MP0004947_skin_inflammation | 1.20212365 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.18920622 |
| 67 | MP0003283_abnormal_digestive_organ | 1.18528593 |
| 68 | MP0005360_urolithiasis | 1.17882434 |
| 69 | MP0009046_muscle_twitch | 1.17231279 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.16714922 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.16682006 |
| 72 | MP0003045_fibrosis | 1.16314337 |
| 73 | MP0004270_analgesia | 1.16043880 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.14652314 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 1.14257868 |
| 76 | MP0002723_abnormal_immune_serum | 1.14240055 |
| 77 | MP0005310_abnormal_salivary_gland | 1.10765704 |
| 78 | MP0000343_altered_response_to | 1.09773631 |
| 79 | MP0004885_abnormal_endolymph | 1.08983505 |
| 80 | MP0000751_myopathy | 1.08157898 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 1.06811396 |
| 82 | MP0005166_decreased_susceptibility_to | 1.06689339 |
| 83 | MP0003448_altered_tumor_morphology | 1.06121855 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.05125580 |
| 85 | MP0002006_tumorigenesis | 1.02903870 |
| 86 | MP0009840_abnormal_foam_cell | 1.02367233 |
| 87 | MP0002429_abnormal_blood_cell | 1.02244520 |
| 88 | MP0001849_ear_inflammation | 1.02194389 |
| 89 | MP0000747_muscle_weakness | 1.00505471 |
| 90 | MP0004233_abnormal_muscle_weight | 1.00365927 |
| 91 | MP0002452_abnormal_antigen_presenting | 0.99042425 |
| 92 | MP0002572_abnormal_emotion/affect_behav | 0.97789221 |
| 93 | MP0005365_abnormal_bile_salt | 0.97490970 |
| 94 | MP0008874_decreased_physiological_sensi | 0.97100865 |
| 95 | MP0003828_pulmonary_edema | 0.96836533 |
| 96 | MP0001835_abnormal_antigen_presentation | 0.96662469 |
| 97 | MP0003633_abnormal_nervous_system | 0.95565259 |
| 98 | MP0004381_abnormal_hair_follicle | 0.95054017 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.94926718 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.94789752 |
| 101 | MP0003690_abnormal_glial_cell | 0.94474780 |
| 102 | MP0003879_abnormal_hair_cell | 0.93197682 |
| 103 | MP0003075_altered_response_to | 0.92964243 |
| 104 | MP0002933_joint_inflammation | 0.92148759 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.91227160 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.89578322 |
| 107 | MP0004883_abnormal_blood_vessel | 0.88716059 |
| 108 | MP0009763_increased_sensitivity_to | 0.88329268 |
| 109 | MP0001663_abnormal_digestive_system | 0.87232740 |
| 110 | MP0000609_abnormal_liver_physiology | 0.86349822 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.86075452 |
| 112 | MP0005164_abnormal_response_to | 0.84904583 |
| 113 | MP0000955_abnormal_spinal_cord | 0.84409970 |
| 114 | MP0000490_abnormal_crypts_of | 0.84315454 |
| 115 | MP0004858_abnormal_nervous_system | 0.83603863 |
| 116 | MP0005390_skeleton_phenotype | 0.83416873 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.83210928 |
| 118 | MP0003252_abnormal_bile_duct | 0.82889925 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.80316132 |
| 120 | MP0005083_abnormal_biliary_tract | 0.79729078 |
| 121 | MP0003091_abnormal_cell_migration | 0.79333249 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.77722546 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.77722546 |
| 124 | MP0002269_muscular_atrophy | 0.77320756 |
| 125 | MP0005023_abnormal_wound_healing | 0.77302874 |
| 126 | MP0001851_eye_inflammation | 0.77026097 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.76757584 |
| 128 | MP0008770_decreased_survivor_rate | 0.76621845 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.75978920 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.75026207 |
| 131 | MP0002254_reproductive_system_inflammat | 0.74804439 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.74735637 |
| 133 | MP0002139_abnormal_hepatobiliary_system | 0.74300760 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.73986201 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.73727532 |
| 136 | MP0003787_abnormal_imprinting | 0.72827476 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.71757268 |
| 138 | MP0001501_abnormal_sleep_pattern | 0.71693285 |
| 139 | MP0008872_abnormal_physiological_respon | 0.71024930 |
| 140 | MP0000249_abnormal_blood_vessel | 0.71023544 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.69290310 |
| 142 | MP0002138_abnormal_hepatobiliary_system | 0.69223932 |
| 143 | MP0005386_behavior/neurological_phenoty | 0.68762664 |
| 144 | MP0004924_abnormal_behavior | 0.68762664 |
| 145 | MP0002272_abnormal_nervous_system | 0.68477423 |
| 146 | MP0010352_gastrointestinal_tract_polyps | 0.67614870 |
| 147 | MP0001944_abnormal_pancreas_morphology | 0.66983385 |
| 148 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64949971 |
| 149 | MP0003566_abnormal_cell_adhesion | 0.64287107 |
| 150 | MP0003795_abnormal_bone_structure | 0.61322775 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.60975410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.41946941 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.28553118 |
| 3 | Myositis (HP:0100614) | 4.19431265 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.99210346 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.89271199 |
| 6 | Hyperacusis (HP:0010780) | 3.80320655 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77427100 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77427100 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77427100 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.70699783 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.62433158 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.57194946 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.40588956 |
| 14 | Increased serum ferritin (HP:0003281) | 3.33650009 |
| 15 | Orchitis (HP:0100796) | 3.32255887 |
| 16 | Hemiplegia (HP:0002301) | 3.27214186 |
| 17 | Insomnia (HP:0100785) | 3.20899999 |
| 18 | Stomatitis (HP:0010280) | 3.20271617 |
| 19 | Abnormality of the fingertips (HP:0001211) | 3.20082659 |
| 20 | Visual hallucinations (HP:0002367) | 3.14255797 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13934508 |
| 22 | Obstructive lung disease (HP:0006536) | 3.13934508 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.08925128 |
| 24 | Cerebral aneurysm (HP:0004944) | 3.03724460 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.02847717 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.99957446 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.99106346 |
| 28 | Optic neuritis (HP:0100653) | 2.99106346 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.95552163 |
| 30 | Macroorchidism (HP:0000053) | 2.89833511 |
| 31 | Myokymia (HP:0002411) | 2.89357344 |
| 32 | Pustule (HP:0200039) | 2.81723402 |
| 33 | Meningitis (HP:0001287) | 2.79246862 |
| 34 | Elfin facies (HP:0004428) | 2.75841982 |
| 35 | Loss of speech (HP:0002371) | 2.75019666 |
| 36 | Pointed chin (HP:0000307) | 2.73474503 |
| 37 | Purpura (HP:0000979) | 2.72561193 |
| 38 | T lymphocytopenia (HP:0005403) | 2.71761309 |
| 39 | Abnormal social behavior (HP:0012433) | 2.70907344 |
| 40 | Impaired social interactions (HP:0000735) | 2.70907344 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.68873292 |
| 42 | Ankle clonus (HP:0011448) | 2.66833692 |
| 43 | Gingivitis (HP:0000230) | 2.62351446 |
| 44 | Increased IgM level (HP:0003496) | 2.62190371 |
| 45 | Abnormality of iron homeostasis (HP:0011031) | 2.61926986 |
| 46 | Increased IgE level (HP:0003212) | 2.61783241 |
| 47 | Abnormality of complement system (HP:0005339) | 2.60852425 |
| 48 | Complement deficiency (HP:0004431) | 2.56905103 |
| 49 | Neoplasm of the heart (HP:0100544) | 2.55863710 |
| 50 | Urinary urgency (HP:0000012) | 2.54252838 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52961024 |
| 52 | Depression (HP:0000716) | 2.52314227 |
| 53 | Dysmetric saccades (HP:0000641) | 2.50481704 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.50466830 |
| 55 | Recurrent skin infections (HP:0001581) | 2.46921907 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.46570138 |
| 57 | Cellulitis (HP:0100658) | 2.45596311 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.44695445 |
| 59 | Amyloidosis (HP:0011034) | 2.44539897 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44184119 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43381819 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43381819 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43381819 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.40864672 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.39982031 |
| 66 | Heterotopia (HP:0002282) | 2.39045677 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 2.38146718 |
| 68 | Upper limb amyotrophy (HP:0009129) | 2.38146718 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.37927257 |
| 70 | Urticaria (HP:0001025) | 2.36278144 |
| 71 | Focal seizures (HP:0007359) | 2.34257958 |
| 72 | Abnormality of oral frenula (HP:0000190) | 2.34198306 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.34149751 |
| 74 | Resting tremor (HP:0002322) | 2.32575681 |
| 75 | Amyotrophic lateral sclerosis (HP:0007354) | 2.31797356 |
| 76 | Hypertensive crisis (HP:0100735) | 2.30278030 |
| 77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.30040215 |
| 78 | Fatigue (HP:0012378) | 2.30002622 |
| 79 | Vasculitis (HP:0002633) | 2.29014830 |
| 80 | Colitis (HP:0002583) | 2.28577916 |
| 81 | Renovascular hypertension (HP:0100817) | 2.28391313 |
| 82 | Encephalitis (HP:0002383) | 2.28222375 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27981944 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.27981944 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27425518 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.23374938 |
| 87 | Supranuclear gaze palsy (HP:0000605) | 2.21570477 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.20660078 |
| 89 | Hand muscle atrophy (HP:0009130) | 2.19105622 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.18660332 |
| 91 | Recurrent viral infections (HP:0004429) | 2.18464415 |
| 92 | Poor eye contact (HP:0000817) | 2.17779920 |
| 93 | Hypertriglyceridemia (HP:0002155) | 2.17388774 |
| 94 | J-shaped sella turcica (HP:0002680) | 2.15470597 |
| 95 | Spastic gait (HP:0002064) | 2.14514939 |
| 96 | Glomerulonephritis (HP:0000099) | 2.14263157 |
| 97 | Epistaxis (HP:0000421) | 2.14135944 |
| 98 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.13769228 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.13467866 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.12245190 |
| 101 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12218990 |
| 102 | Impaired smooth pursuit (HP:0007772) | 2.11804252 |
| 103 | Overriding aorta (HP:0002623) | 2.10743983 |
| 104 | Bundle branch block (HP:0011710) | 2.10261779 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.09590127 |
| 106 | Vertebral compression fractures (HP:0002953) | 2.09438062 |
| 107 | Papilloma (HP:0012740) | 2.08288146 |
| 108 | Verrucae (HP:0200043) | 2.08288146 |
| 109 | Papilledema (HP:0001085) | 2.07839525 |
| 110 | Striae distensae (HP:0001065) | 2.06403388 |
| 111 | Postural instability (HP:0002172) | 2.05429683 |
| 112 | Long toe (HP:0010511) | 2.05371062 |
| 113 | Petechiae (HP:0000967) | 2.05311541 |
| 114 | Chronic otitis media (HP:0000389) | 2.04634896 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03388486 |
| 116 | Keratoconjunctivitis sicca (HP:0001097) | 2.03166308 |
| 117 | Myocardial infarction (HP:0001658) | 2.02878267 |
| 118 | Granulocytopenia (HP:0001913) | 2.02326454 |
| 119 | Clonus (HP:0002169) | 2.01967200 |
| 120 | Truncal ataxia (HP:0002078) | 2.01808365 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.99957756 |
| 122 | Abnormality of T cells (HP:0002843) | 1.99943050 |
| 123 | Recurrent bronchitis (HP:0002837) | 1.99622293 |
| 124 | Obsessive-compulsive behavior (HP:0000722) | 1.99171697 |
| 125 | Joint hemorrhage (HP:0005261) | 1.98709103 |
| 126 | Broad metatarsal (HP:0001783) | 1.97527196 |
| 127 | Annular pancreas (HP:0001734) | 1.96452720 |
| 128 | Status epilepticus (HP:0002133) | 1.95412380 |
| 129 | Nasal polyposis (HP:0100582) | 1.94638006 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93060811 |
| 131 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91257651 |
| 132 | Pseudobulbar signs (HP:0002200) | 1.90900313 |
| 133 | Deep palmar crease (HP:0006191) | 1.90847810 |
| 134 | Hemoptysis (HP:0002105) | 1.90159082 |
| 135 | Frequent falls (HP:0002359) | 1.90011787 |
| 136 | Prolonged bleeding time (HP:0003010) | 1.89963195 |
| 137 | Axonal loss (HP:0003447) | 1.89361613 |
| 138 | Gingival bleeding (HP:0000225) | 1.87643721 |
| 139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86574034 |
| 140 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86574034 |
| 141 | Stridor (HP:0010307) | 1.86197417 |
| 142 | Ependymoma (HP:0002888) | 1.85881998 |
| 143 | Gangrene (HP:0100758) | 1.85301854 |
| 144 | Renal duplication (HP:0000075) | 1.84457956 |
| 145 | Aneurysm (HP:0002617) | 1.83674083 |
| 146 | Pulmonary embolism (HP:0002204) | 1.83504964 |
| 147 | Tetraplegia (HP:0002445) | 1.83307603 |
| 148 | Abnormality of the nasal mucosa (HP:0000433) | 1.83071506 |
| 149 | Polycythemia (HP:0001901) | 1.82971482 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.82958846 |
| 151 | Bowel diverticulosis (HP:0005222) | 1.82506511 |
| 152 | Nuclear cataract (HP:0100018) | 1.82483647 |
| 153 | Thoracic kyphosis (HP:0002942) | 1.81786688 |
| 154 | Arterial thrombosis (HP:0004420) | 1.81700033 |
| 155 | Aortic aneurysm (HP:0004942) | 1.81477056 |
| 156 | Xanthomatosis (HP:0000991) | 1.80393269 |
| 157 | Severe short stature (HP:0003510) | 1.79916584 |
| 158 | Joint swelling (HP:0001386) | 1.78910229 |
| 159 | Glomerulopathy (HP:0100820) | 1.78791510 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.78591191 |
| 161 | Radial bowing (HP:0002986) | 1.77039915 |
| 162 | Chest pain (HP:0100749) | 1.76582834 |
| 163 | Long palpebral fissure (HP:0000637) | 1.74608604 |
| 164 | Neuronal loss in central nervous system (HP:0002529) | 1.74519362 |
| 165 | Basal cell carcinoma (HP:0002671) | 1.74259653 |
| 166 | Abnormality of binocular vision (HP:0011514) | 1.73815899 |
| 167 | Diplopia (HP:0000651) | 1.73815899 |
| 168 | Narrow palate (HP:0000189) | 1.73612318 |
| 169 | Ankyloglossia (HP:0010296) | 1.73233797 |
| 170 | Action tremor (HP:0002345) | 1.71056968 |
| 171 | Dilatation of the ascending aorta (HP:0005111) | 1.70333580 |
| 172 | Recurrent fungal infections (HP:0002841) | 1.69395548 |
| 173 | Vertebral arch anomaly (HP:0008438) | 1.69391341 |
| 174 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69191210 |
| 175 | Broad palm (HP:0001169) | 1.67353646 |
| 176 | Bradykinesia (HP:0002067) | 1.66621337 |
| 177 | Focal motor seizures (HP:0011153) | 1.66034728 |
| 178 | Sacral dimple (HP:0000960) | 1.64500517 |
| 179 | Agammaglobulinemia (HP:0004432) | 1.64289232 |
| 180 | Autoimmune thrombocytopenia (HP:0001973) | 1.62457573 |
| 181 | Polygenic inheritance (HP:0010982) | 1.61057588 |
| 182 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.60066132 |
| 183 | Short 4th metacarpal (HP:0010044) | 1.59475696 |
| 184 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.59475696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.81367473 |
| 2 | PKN2 | 3.20302873 |
| 3 | NME2 | 3.01968908 |
| 4 | MAP4K1 | 2.98838027 |
| 5 | MAP3K11 | 2.81223628 |
| 6 | RIPK1 | 2.72680877 |
| 7 | SIK2 | 2.69837863 |
| 8 | EEF2K | 2.65697038 |
| 9 | MAP3K10 | 2.59030774 |
| 10 | PRPF4B | 2.55886138 |
| 11 | IRAK3 | 2.52748549 |
| 12 | TESK2 | 2.47935704 |
| 13 | MAP3K14 | 2.17480859 |
| 14 | FGFR4 | 2.17068661 |
| 15 | MAP2K3 | 2.13717500 |
| 16 | RIPK4 | 2.07952760 |
| 17 | SMG1 | 2.07071779 |
| 18 | IRAK4 | 1.98971600 |
| 19 | MAP3K9 | 1.98428393 |
| 20 | TAOK2 | 1.75409532 |
| 21 | BLK | 1.74400538 |
| 22 | MAP3K3 | 1.72818973 |
| 23 | MAP3K13 | 1.70756375 |
| 24 | MAP3K7 | 1.69418058 |
| 25 | TYRO3 | 1.67711231 |
| 26 | ERN1 | 1.63878422 |
| 27 | SIK1 | 1.62661896 |
| 28 | TAOK1 | 1.55486804 |
| 29 | GRK6 | 1.53303029 |
| 30 | PRKCH | 1.52960625 |
| 31 | ITK | 1.51598474 |
| 32 | ZAP70 | 1.48387221 |
| 33 | JAK1 | 1.47949359 |
| 34 | DAPK2 | 1.45057331 |
| 35 | TYK2 | 1.40934675 |
| 36 | CAMKK1 | 1.39955175 |
| 37 | PAK6 | 1.38919093 |
| 38 | KSR2 | 1.38366218 |
| 39 | TTN | 1.35786384 |
| 40 | KDR | 1.33260697 |
| 41 | JAK3 | 1.31122469 |
| 42 | PTK6 | 1.30168476 |
| 43 | STK38 | 1.28058672 |
| 44 | MARK2 | 1.25002277 |
| 45 | ALK | 1.24527367 |
| 46 | IKBKB | 1.23916155 |
| 47 | EPHA4 | 1.23809500 |
| 48 | NTRK2 | 1.23395950 |
| 49 | PRKD3 | 1.23237985 |
| 50 | TESK1 | 1.21916146 |
| 51 | EPHB1 | 1.20241619 |
| 52 | PIM2 | 1.16790352 |
| 53 | PDGFRA | 1.16394118 |
| 54 | CAMK1G | 1.08382430 |
| 55 | CDC42BPA | 1.07601795 |
| 56 | MAP2K2 | 1.06969627 |
| 57 | MARK1 | 1.04520125 |
| 58 | MAP3K1 | 1.02296279 |
| 59 | LMTK2 | 1.01821160 |
| 60 | FLT3 | 1.01261385 |
| 61 | FES | 1.00750587 |
| 62 | MATK | 0.99639131 |
| 63 | FGR | 0.98338977 |
| 64 | IRAK2 | 0.97539930 |
| 65 | NTRK3 | 0.97250728 |
| 66 | DAPK1 | 0.95872350 |
| 67 | FGFR3 | 0.95695218 |
| 68 | RET | 0.95188897 |
| 69 | STK10 | 0.95063311 |
| 70 | JAK2 | 0.94897767 |
| 71 | EPHA2 | 0.91954651 |
| 72 | KSR1 | 0.90252043 |
| 73 | SCYL2 | 0.87996523 |
| 74 | ICK | 0.87258027 |
| 75 | HCK | 0.85851573 |
| 76 | PAK4 | 0.85803285 |
| 77 | LRRK2 | 0.85497658 |
| 78 | PDK1 | 0.83562556 |
| 79 | TXK | 0.82018822 |
| 80 | MINK1 | 0.81180312 |
| 81 | LYN | 0.80533495 |
| 82 | HIPK2 | 0.73754065 |
| 83 | BTK | 0.73010052 |
| 84 | SYK | 0.72925646 |
| 85 | IKBKE | 0.72594327 |
| 86 | MAPK7 | 0.71906250 |
| 87 | MAPK11 | 0.71190412 |
| 88 | TAOK3 | 0.70659511 |
| 89 | CDK5 | 0.70541847 |
| 90 | PHKG2 | 0.69181855 |
| 91 | PHKG1 | 0.69181855 |
| 92 | STK11 | 0.68962042 |
| 93 | UHMK1 | 0.67392558 |
| 94 | CDK12 | 0.65379085 |
| 95 | BCKDK | 0.64725189 |
| 96 | LCK | 0.64661214 |
| 97 | CAMK1D | 0.64548112 |
| 98 | MTOR | 0.64061614 |
| 99 | GRK7 | 0.63284113 |
| 100 | DYRK1B | 0.63159533 |
| 101 | PIM1 | 0.61741539 |
| 102 | CAMK4 | 0.61717951 |
| 103 | TBK1 | 0.61279715 |
| 104 | ARAF | 0.61161412 |
| 105 | PDGFRB | 0.60047340 |
| 106 | TGFBR2 | 0.60039281 |
| 107 | PRKD2 | 0.59850256 |
| 108 | CSF1R | 0.59832454 |
| 109 | CAMK1 | 0.59127267 |
| 110 | CHUK | 0.58808282 |
| 111 | SGK3 | 0.58244312 |
| 112 | KIT | 0.58077334 |
| 113 | TNK2 | 0.58047820 |
| 114 | RPS6KC1 | 0.56483693 |
| 115 | RPS6KL1 | 0.56483693 |
| 116 | FGFR2 | 0.54953886 |
| 117 | BMX | 0.54831423 |
| 118 | MARK3 | 0.54054356 |
| 119 | ABL2 | 0.53941504 |
| 120 | PTK2 | 0.53528773 |
| 121 | RAF1 | 0.53007252 |
| 122 | CSK | 0.52347754 |
| 123 | FYN | 0.51909401 |
| 124 | MAP2K6 | 0.51575807 |
| 125 | MAPKAPK2 | 0.49677816 |
| 126 | BRSK1 | 0.49627308 |
| 127 | DMPK | 0.47396053 |
| 128 | MOS | 0.46533681 |
| 129 | PRKD1 | 0.46522518 |
| 130 | MAP3K8 | 0.46099282 |
| 131 | RPS6KA2 | 0.45772423 |
| 132 | PDPK1 | 0.44422459 |
| 133 | NTRK1 | 0.44323238 |
| 134 | MAP3K4 | 0.43750108 |
| 135 | PAK3 | 0.43079746 |
| 136 | CAMKK2 | 0.42150203 |
| 137 | NEK2 | 0.41663891 |
| 138 | SIK3 | 0.41292048 |
| 139 | MAPKAPK3 | 0.40681428 |
| 140 | RPS6KA6 | 0.40354783 |
| 141 | WNK1 | 0.40128640 |
| 142 | CDK6 | 0.39312927 |
| 143 | CDK4 | 0.39252519 |
| 144 | RPS6KA3 | 0.39029405 |
| 145 | MAPK12 | 0.38914257 |
| 146 | MST1R | 0.35092481 |
| 147 | DDR2 | 0.34903651 |
| 148 | MAP3K6 | 0.33059120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.30703129 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79093269 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52340620 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44167726 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39314448 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.23151505 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20207729 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18542539 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12593534 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05172822 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95676433 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.88536317 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86833002 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.79266853 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78676251 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70089384 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.69585755 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64849460 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63959207 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60444997 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.58294319 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.58228657 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56395978 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.56253532 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.56139371 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53527043 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52827965 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49774330 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49518476 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48977363 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.48541223 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48345029 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45338245 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.44676062 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.41418711 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.41318347 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40924185 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.40428068 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.40082479 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.39718493 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38594605 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36912764 |
| 43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.36612106 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34553327 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34141863 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33782098 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33005927 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 1.29896928 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.29066822 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 1.25366648 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24948288 |
| 52 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24370023 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22286057 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.22226281 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 1.22147793 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20703816 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20318023 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.19354206 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19292758 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17621128 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17094693 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 1.16935877 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 1.16907418 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 1.16076953 |
| 65 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15980056 |
| 66 | Asthma_Homo sapiens_hsa05310 | 1.14965739 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14532863 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14257336 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.14174974 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 1.14144798 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13872408 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13673080 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12671065 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12024104 |
| 75 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11969326 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11773362 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.08495567 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08326988 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08163879 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99154925 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.98559040 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98524152 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98004593 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97215265 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.96587652 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96160119 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95373360 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95124154 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93360501 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93227545 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93117591 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90595220 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89963224 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89913474 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89747926 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89331231 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88901042 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.88372278 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87531357 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87047371 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86854734 |
| 102 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86252787 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.86200686 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.84453366 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82731173 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82433543 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82365772 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81601214 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.81501542 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81391682 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80295437 |
| 112 | Nicotine addiction_Homo sapiens_hsa05033 | 0.79969221 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79160763 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79086744 |
| 115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77872551 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77135670 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75944154 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.74779930 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74180044 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.73960319 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73773019 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73494526 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72146130 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71686876 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71621132 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71219490 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71088197 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69672992 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68940675 |
| 130 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65006424 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63515768 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63444316 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62719404 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62484455 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62415212 |
| 136 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62186049 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.60792977 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60481390 |
| 139 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59435369 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.58525275 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.58325779 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58005838 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57070534 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56627215 |
| 145 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53153662 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53107596 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53096559 |
| 148 | Melanogenesis_Homo sapiens_hsa04916 | 0.52690044 |
| 149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52671389 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.52429806 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52398049 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50888602 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47665787 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47104129 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44682883 |
| 156 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42287827 |
| 157 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35959107 |
| 158 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35794157 |
| 159 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35519447 |
| 160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34725541 |
| 161 | Base excision repair_Homo sapiens_hsa03410 | 0.34317843 |
| 162 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33796517 |
| 163 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31593270 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27663579 |
| 165 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27373277 |

